(Q34606528)

3 August 2017

title

Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition (English)

1 reference

chronic intestinal pseudoobstruction

3 August 2017

main subject

0 references

author name string

Aurelien Amiot

1

1 reference

3 August 2017

Francisca Joly

2

1 reference

3 August 2017

Arnaud Alves

3

1 reference

3 August 2017

Yves Panis

4

1 reference

3 August 2017

Yoram Bouhnik

5

1 reference

3 August 2017

Bernard Messing

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

14 April 2009

1 reference

The American Journal of Gastroenterology

3 August 2017

published in

1 reference

3 August 2017

volume

104

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

1262-1270

1 reference

Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Pseudo-obstruction: current approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Deranged smooth muscle alpha-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Loss of CD117 (c-kit)- and CD34-positive ICC and associated CD34-positive fibroblasts defines a subpopulation of chronic intestinal pseudo-obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Chronic Intestinal Pseudo-Obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Guidelines for management of patients with a short bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Chronic intestinal pseudo-obstruction: assessment and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Nutritional management of chronic intestinal pseudo-obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Chronic intestinal pseudo-obstruction: treatment and long term follow up of 44 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Long-term outcome of congenital intestinal pseudoobstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

2003 report of the intestine transplant registry: a new era has dawned

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Current status of transplantation of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

A Biometric Study of Human Basal Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Intestinal failure-associated liver disease: what do we know today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Guidelines for management of home parenteral support in adult chronic intestinal failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Net digestive absorption and adaptive hyperphagia in adult short bowel patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Home parenteral nutrition: survival, cost, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Treatment of end stage chronic intestinal pseudo-obstruction by subtotal enterectomy and home parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Cyclophosphamide versus placebo in scleroderma lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Analysis of acute cellular rejection episodes in recipients of primary intestinal transplantation: a single center, 11-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

The current status of small bowel transplantation in the UK and internationally

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.58

21 January 2018

Identifiers

DOI

10.1038/AJG.2009.58

1 reference

3 August 2017

1 reference